Be The Match BioTherapies logo

Be The Match BioTherapies

North America, Minnesota, United States, Minneapolis

Description

Be The Match BioTherapies® is built on the foundation established by our parent company.

Investor Profile

Be The Match BioTherapies has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (40%)
  • Series A (40%)
  • Series C (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Genetics
  • Health Care
  • Manufacturing
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Be The Match BioTherapies frequently co-invest with?

Access Industries
North America, New York, United States, New York
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Gilead Sciences
North America, California, United States, Foster City
Co-Investments: 3
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
Parker Institute for Cancer Immunotherapy
North America, California, United States, San Francisco
Co-Investments: 2
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Ping An Ventures
Asia, Shandong, China, Pudong
Co-Investments: 2
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
University of Pennsylvania
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by Be The Match BioTherapies?

Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series BOct 31, 2019
Amount Raised: $75,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AApr 19, 2018
Amount Raised: $35,000,000
Magenta Therapeutics

Cambridge, Massachusetts, United States

Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.

BiotechnologyMedicalTherapeutics
Series CApr 9, 2018
Amount Raised: $52,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AJan 23, 2018
Amount Raised: $100,000,000
Magenta Therapeutics

Cambridge, Massachusetts, United States

Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.

BiotechnologyMedicalTherapeutics
Series BMay 2, 2017
Amount Raised: $50,000,000